Inhibition of carcinoma cell growth and metastasis by a vesicular stomatitis virus G-pseudotyped retrovector expressing type I insulin-like growth factor receptor antisense
Aa. Samani et al., Inhibition of carcinoma cell growth and metastasis by a vesicular stomatitis virus G-pseudotyped retrovector expressing type I insulin-like growth factor receptor antisense, HUM GENE TH, 12(16), 2001, pp. 1969-1977
A replication-defective, vesicular stomatitis virus G-pseudotyped, Moloney
murine leukemia virus retroviral vector (vLTR-IGF-IRAS) was generated in wh
ich a type I insulin-like growth factor receptor (IGF-IR) antisense fragmen
t is expressed in a bicistronic mRNA with an enhanced green fluorescent pro
tein (EGFP) reporter under the control of a potent long terminal repeat (LT
R). The suitability of these retroparticles for gene therapy was tested wit
h highly metastatic, carcinoma H-59 cells, which depend on IGF-IR expressio
n for tumorigenicity and metastasis. Transduction with these, but not with
control retroviral particles expressing EGFP only, resulted in a 70% reduct
ion in IGF-IR levels and the loss of IGF-IR-regulated functions. Moreover,
the ability of vLTR-IGF-IRAS retroparticle-transduced tumor cells to form e
xperimental hepatic metastases was significantly reduced relative to contro
ls. The results identify retrovector-mediated delivery of IGF-IR antisense
as a potential strategy for cancer gene therapy.